title: Improving efficacy of the combination between antiangiogenic and chemotherapy: Time for mathematical modeling support.
authors.affiliation: SMARTc Unit, Pharmacokinetics Laboratory, Inserm S_911 CRO2 Aix Marseille University, and La Timone University Hospital of Marseille, 13000 Marseille, France; fabrice.barlesi@ap-hm.fr.
authors.forename: Joseph
authors.initials: J
authors.lastname: Ciccolini
authors.affiliation: Modelling, Control, and Computations Unit, Institut National de Recherche en Informatique et en Automatique, 33000 Bordeaux, France;
authors.forename: Sébastien
authors.initials: S
authors.lastname: Benzekry
authors.affiliation: SMARTc Unit, Pharmacokinetics Laboratory, Inserm S_911 CRO2 Aix Marseille University, and La Timone University Hospital of Marseille, 13000 Marseille, France; Clinical Pharmacokinetics Laboratory, Assistance Publique, Hopitaux de Marseille, 13000 Marseille, France;
authors.forename: Bruno
authors.initials: B
authors.lastname: Lacarelle
authors.affiliation: SMARTc Unit, Pharmacokinetics Laboratory, Inserm S_911 CRO2 Aix Marseille University, and La Timone University Hospital of Marseille, 13000 Marseille, France;
authors.forename: Dominique
authors.initials: D
authors.lastname: Barbolosi
authors.affiliation: SMARTc Unit, Pharmacokinetics Laboratory, Inserm S_911 CRO2 Aix Marseille University, and La Timone University Hospital of Marseille, 13000 Marseille, France; Multidisciplinary Oncology and Therapeutic Innovations Unit, Nord University Hospital of Marseille, 13000 Marseille, France fabrice.barlesi@ap-hm.fr.
authors.forename: Fabrice
authors.initials: F
authors.lastname: Barlési
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A